Background: Acute pulmonary embolism (PE) is a cardiovascular disease with symptoms
including respiratory associated chest pain (RACP) and dyspnea. No previous studies exist …

Background The rate or persistent perfusion defects after acute pulmonary embolism (PE)
varies from 30% to 50% after 6 months of treatment. Moreover, PE patients may suffer from …

Background There is no research, either at home or abroad, focusing on assessing the
cardiopulmonary functional reserve and exercise tolerance in patients with pulmonary …

Abstract Background The Post-Pulmonary Embolism Syndrome (PPES) comprises
heterogeneous entities, including chronic thromboembolic disease with/without pulmonary …

Background Venous thromboembolism is a life-threatening disease. In survivors, different
degrees of functional complaints need to be restored or prevented (eg, post-thrombotic …

Introduction There is an increasing awareness that patients with acute pulmonary embolism
(APE) suffer long-term consequences like fatigue, anxiety, and reduced physical capacity …

Pulmonary embolism (PE) is a major cause of acute cardiovascular mortality and long-term
morbidity. Right ventricular (RV) dysfunction is the key determinant of prognosis in the acute …

Background Exercise training after myocardial infarction is the standard of care within a
cardiac rehabilitation setting. However, there is scant evidence regarding the safety and …

Background and hypothesis: Hemodynamic and functional consequences of acute
pulmonary embolism (APE) are believed to be reversible with antithrombotic treatment. To …

Introduction Acute pulmonary embolism (PE) is a disease with a broad spectrum of clinical
presentations. While some patients can be treated at home or may even be left untreated …